Rodney Davis, MD

Rodney Davis, MD

Urology Little Rock, AR

Professor and Chair, Department of Urology University of Arkansas for Medical Sciences

Office Address

Office Map
  • 4301 W. Markham Street
    Little Rock, AR 72205
    Phone: (501) 686-7642
    Fax: (501) 686-5277

Dr. Davis's Clinical Specialties & Interests

  • Urology: Surgical Oncology, Minimally Invasive Surgery
  • Clinical Interests: Oncology; Lapar; Robotic; robotic

Dr. Davis's Faculty Appointments & Work History

  • Chief of UrologyTennessee Valley Veterans Health Care System
    Nashville, TN
  • Chief of UrologyMeharry Medical College
    Nashville, TN
  • Professor and ChairUniversity of Arkansas for Medical Sciences
    Little Rock, AR
  • Professor of UrologyVanderbilt University Medical Center
    Nashville, TN
  • Associate Professor of UrologyUniversity School of Medicine
    New Orleans, LA
  • LecturerSection of Urology, University of Michigan Medical Center
    Ann Arbor, MI
  • ChiefVeteran’s Administration Medical Center
    Ann Arbor, MI
  • Assistant ChiefMadigan Army Medical Center
    Tacoma, WA
    Staff Urologists (1989-1992)

Dr. Davis's Education & Medical Training

  • Madigan Healthcare SystemMadigan Healthcare SystemResidency, Urology
  • Madigan Healthcare SystemMadigan Healthcare SystemResidency, General Surgery
  • Tulane Univ Sch of MedTulane University School of MedicineMedical School

Dr. Davis's Certifications & Licensure

  • AR State Medical LicenseAR State Medical License2012 - 2015
  • LA State Medical LicenseLA State Medical LicenseActive through 2013
  • TN State Medical LicenseTN State Medical LicenseActive through 2013
  • American Board of UrologyAmerican Board of UrologyUrology, 1989

Dr. Davis's Awards, Honors, & Recognition

  • Robert S. McCleery Endowed Award for Master Teacher for Surgical Resident Education.2012
  • • America’s Top Surgeons by Consumers’ Research Council of America.2010
  • The Best Doctors in America Award2005
  • Register to See 9 More...

Dr. Davis's Publications & Presentations

PubMed | Citations by Web of Science®

Journal Articles

  • Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium.Hayn MH, Hellenthal NJ, Hussain A, Andrews PE, Carpentier P, Castle E, Dasgupta P, Davis R, Thomas R, Khan S, Kibel A, Kim H, Manoharan M, Menon M, Mottrie A, Ornstein..., Urology. 76(5):1111-6. PMID: 20709372
  • Urinary Collecting System Invasion is a Predictor for Overall and Disease-Specific Survival in Locally Invasive Renal Cell Carcinoma.Anderson CB, Clark PE, Morgan TM, Stratton KL, Herrell SD, Davis R, Cookson MS, Smith JA Jr, Chang SS, Urology.78(1):99-104. PMID:21550647
  • Multi-Institutional Analysis of Robotic Radical Cystectomy for Bladder Cancer: Perioperative Outcomes and Complications in 227 Patients.Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, Nielsen M, Thomas R, Wallen EM, Woods M, Pruthi RS, J Laparoendosc Adv Surg Tech A
  • Register to See 50 More...

Books/Book Chapters

  • Clinical OncologyChapter: Diagnosis and Treatment of Urinary Obstruction in Malignant Disease.Page 599 - 608
    Davis R. and Richard-Davis G
    Editors: Abeloff M.D., Armitage J.O., Litcher A.S. Niederhuler J.E.
  • Management of erectile dysfunction following radical prostatectomy. In Male Sexual Function.Chapter: A Guide to clinical Management published in the Current Clinical Urology series by The Humana Press
    Novak T.E., Bivalacqua T.J. Davis R., and Hellstrom WJG
    Editors: .
  • In Advanced Therapy of Prostate Disease.Chapter: The case for observation.
    Rozanski T.A. and Davis R
    Editors: Martin Resnick and Ian Thompson..


  • Re-expression of functional androgen receptor in PC-3 cells confers sensitization to radiation and anticancer drugs.R. Davis, D. Jia, B. Cinar, S. C. Sikka, K. Moparty, H. E. Zhau, L.W. Chung, K.C. Agrawal and A. B. Abdel-Mageed, Proc. Amer. Assoc. Cancer Res., 44:353, AACR meeting, Washington, DC
  • Functional androgen receptor chemosensitizes prostate cancer cells to anticancer drugs and radiation.R. Davis, D. Jia, B. Cinar, S. C. Sikka, K. Moparty, H. E. Zhau, L.W. Chung, K.C. Agrawal and A. B. Abdel-Mageed, Cancer Detection and Prevention, pp S-167, ISPO, France
  • AB Role of metallothionein in prostate cancer progression.L. Human, Davis, R, Abdel-Mageed, Proc. Amer. Assoc. Cancer Res.41:432
  • Register to See 9 More...


  • An Analysis of Prognostic Factors (Experience with Three Different Institutions).Charleston, South Carolina.
  • Expression of LH-RH Receptors and mRNA for LH-RH Receptors in Patients with Localized Prostate Cancer.Dallas, Texas.
  • _Isoform-specific gene expression of metallothionein renal cell carcinoma
  • Register to See 67 More...

Physicians, view Dr. Davis's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV